Breaking News

Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer

Supports the expansion of manufacturing volume required for potential additional indications for crofelemer.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jaguar Health, Inc. has successfully completed the registration of the source of the active pharmaceutical ingredient (API) of crofelemer with the Agenzia Italiana Del Farmaco (AIFA), the Italian Medicines Agency. As a result, batches of crofelemer API manufactured by Milan, Italy-based Indena S.P.A. can now be used by Jaguar for further development work.   “We are very pleased about the completion of this key milestone in the ongoing process of establishing Indena as an additional appro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters